APA ציטוט

Thapa, P., Parghane, R., & Basu, S. (2017). (177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites. World J Nucl Med.

Citação norma Chicago

Thapa, Pradeep, Rahul Parghane, and Sandip Basu. "(177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites." World J Nucl Med 2017.

ציטוט MLA

Thapa, Pradeep, Rahul Parghane, and Sandip Basu. "(177)Lu-DOTATATE Peptide Receptor Radionuclide Therapy in Metastatic or Advanced and Inoperable Primary Neuroendocrine Tumors of Rare Sites." World J Nucl Med 2017.

אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.